PHASE-II EVALUATION OF THE SULFONYLUREA LY186,641 IN MEN WITH HORMONE-INDEPENDENT METASTATIC PROSTATE-CANCER

被引：1
|
作者：
WILDING, G
GRINDEY, G
MUNSHI, N
SEITZ, D
EINHORN, L
机构：
[1] WM S MIDDLETON VA HOSP,MADISON,WI
[2] ELI LILLY CORP,LILLY RES LABS,INDIANAPOLIS,IN
[3] INDIANA UNIV,MED CTR,DEPT MED,DIV HEMATOL ONCOL,INDIANAPOLIS,IN 46204
来源：
INVESTIGATIONAL NEW DRUGS | 1993年 / 11卷 / 2-3期
关键词：
D O I：
10.1007/BF00874156
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：203 / 205
页数：3
相关论文
共 50 条
  • [1] PHASE-II STUDY OF SPIROGERMANIUM IN METASTATIC PROSTATE-CANCER
    DEXEUS, FH
    LOGOTHETIS, C
    SAMUELS, ML
    HOSSAN, B
    CANCER TREATMENT REPORTS, 1986, 70 (09): : 1129 - 1130
  • [2] PHASE-I PHASE-II STUDY OF SURAMIN IN HORMONE RESISTANT METASTATIC PROSTATE-CANCER
    VANRIJSWIJK, REN
    VANLOENEN, AC
    HORENBLAS, S
    WAGSTAFF, J
    PINEDO, HM
    EUROPEAN JOURNAL OF CANCER, 1990, 26 (02) : 185 - 185
  • [3] A PHASE-II EVALUATION OF ADRIAMYCIN AND CIS-PLATINUM IN HORMONE RESISTANT PROSTATE-CANCER
    CITRIN, DL
    HOGAN, TF
    CANCER, 1982, 50 (02) : 201 - 206
  • [4] ANDROGEN RECEPTOR MUTATIONS IN HUMAN HORMONE-INDEPENDENT PROSTATE-CANCER
    TAPLIN, ME
    BUBLEY, G
    FRANZ, ME
    BALK, SP
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 239 - 239
  • [5] PHASE-II EVALUATION OF MITOGUAZONE IN METASTATIC HORMONE-RESISTANT PROSTATE-CANCER - A SOUTHEASTERN CANCER STUDY-GROUP TRIAL
    MOORE, MR
    GRAHAM, SD
    BIRCH, R
    IRWIN, L
    CANCER TREATMENT REPORTS, 1987, 71 (01): : 89 - 90
  • [6] METASTATIC PROSTATE-CANCER - PHASE-II CLINICAL-TRIAL OF SPIROGERMANIUM
    BUI, NB
    CHAUVERGNE, J
    BRUNET, R
    RICHAUD, P
    HOERNI, B
    LAGARDE, C
    LEGUILLOU, M
    BULLETIN DU CANCER, 1986, 73 (01) : 65 - 67
  • [7] PHASE-II EVALUATION OF WEEKLY CISPLATIN IN METASTATIC HORMONE-RESISTANT PROSTATE-CANCER - A SOUTHEASTERN CANCER STUDY-GROUP TRIAL
    MOORE, MR
    TRONER, MB
    DESIMONE, P
    BIRCH, R
    IRWIN, L
    CANCER TREATMENT REPORTS, 1986, 70 (04): : 541 - 542
  • [8] Molecular Pathways in the Progression of Hormone-Independent and Metastatic Prostate Cancer
    Wegiel, B.
    Evans, S.
    Hellsten, R.
    Otterbein, L. E.
    Bjartell, A.
    Persson, J. L.
    CURRENT CANCER DRUG TARGETS, 2010, 10 (04) : 392 - 401
  • [9] PHASE-II CLINICAL-STUDY OF PIRARUBICIN IN HORMONE RESISTANT PROSTATE-CANCER
    RAPOPORT, BL
    FALKSON, G
    INVESTIGATIONAL NEW DRUGS, 1992, 10 (02) : 119 - 121
  • [10] PHASE-II TRIAL OF ECHINOMYCIN IN ADVANCED HORMONE-RESISTANT PROSTATE-CANCER
    SHEVRIN, DH
    LAD, TE
    GUINAN, P
    KILTON, LJ
    GREENBURG, A
    JOHNSON, P
    BLOUGH, RR
    HOYER, H
    INVESTIGATIONAL NEW DRUGS, 1994, 12 (01) : 65 - 66
12345